not tagged
not tagged
[]
meng ma of risk of tapering mtx from combo with bdmard/tsdmard in ra in remission. rr 0.90 (95% ci 0.84, 0.97) for maintaining remission over maximum 18 months. authors conclude little risk to stopping - i disagree 10% is &gt;0. #acr22 abstr#0916 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC